275 related articles for article (PubMed ID: 27464795)
1. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778
[TBL] [Abstract][Full Text] [Related]
3. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
[TBL] [Abstract][Full Text] [Related]
4. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical significance of PARP1 protein expression in breast cancer.
Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation proteins in breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan C; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2014 Apr; 144(3):519-30. PubMed ID: 24584753
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response.
Al-Kaabi MM; Alshareeda AT; Jerjees DA; Muftah AA; Green AR; Alsubhi NH; Nolan CC; Chan S; Cornford E; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Mar; 112(5):901-11. PubMed ID: 25688741
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
Hallajian Z; Mahjoubi F; Nafissi N
Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
[TBL] [Abstract][Full Text] [Related]
10. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
[TBL] [Abstract][Full Text] [Related]
11. Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.
Zhang X; Hofmann S; Harbeck N; Jeschke U; Sixou S
Drugs R D; 2017 Dec; 17(4):569-583. PubMed ID: 28879638
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterisation of breast cancer: the role of CDC42.
Chrysanthou E; Gorringe KL; Joseph C; Craze M; Nolan CC; Diez-Rodriguez M; Green AR; Rakha EA; Ellis IO; Mukherjee A
Breast Cancer Res Treat; 2017 Jul; 164(2):317-325. PubMed ID: 28451966
[TBL] [Abstract][Full Text] [Related]
13. Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins.
Asakawa H; Koizumi H; Koike A; Takahashi M; Wu W; Iwase H; Fukuda M; Ohta T
Breast Cancer Res; 2010; 12(2):R17. PubMed ID: 20205718
[TBL] [Abstract][Full Text] [Related]
14. Expression of BRCA1 protein in breast cancer and its prognostic significance.
Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA
Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RAD51 occurs in aggressive prostatic cancer.
Mitra A; Jameson C; Barbachano Y; Sanchez L; Kote-Jarai Z; Peock S; Sodha N; Bancroft E; Fletcher A; Cooper C; Easton D; ; Eeles R; Foster CS
Histopathology; 2009 Dec; 55(6):696-704. PubMed ID: 20002770
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.
Wang YY; Cheng KH; Hung AC; Lo S; Chen PY; Wu YC; Hou MF; Yuan SF
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063232
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]